Company sees 2026 NAREIT FFO per diluted share of $4.74 to $4.79
Company expects 2026 Normalized FFO per diluted share of $4.74 to $4.79
NHI expects 2026 Same Store SHOP NOI growth of 1% to 3% year over year
Overview
U.S. senior housing REIT's Q2 revenue beat analyst expectations, driven by acquisitions and SHOP growth
Net income per diluted share for Q2 rose 45.6% yr/yr, supported by gains from property sales
Company completed large NHC portfolio sale
Result drivers and key details
SHOP EXPANSION - Co said second quarter invested capital in Senior Housing Operating Portfolio (SHOP) rose 137% yr/yr, driving a 188% increase in SHOP NOI, mainly from recent acquisitions
PROPERTY SALES - Gains on dispositions of real estate, including four properties sold in Q2, contributed $22 mln to net income
HIGHER EXPENSES - General and administrative expenses increased 44% yr/yr, mainly due to higher compensation costs and costs related to CFO transition
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialized REITs peer group is "buy"
Wall Street's median 12-month price target for National Health Investors, Inc. is $84.50, about 12.2% above its August 7 closing price of $75.30
The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 23 three months ago
NHI•
